Evidence map›Paper›PMID 28360149›Full record

ArticleHaematologica2017

Jana Hof, Corinne Kox, Stefanie Groeneveld-Krentz, Obul R Bandapalli, Leonid Karawajew, Katharina Schedel, Joachim B Kunz, Cornelia Eckert, Wolf-Dieter Ludwig, Richard Ratei and 6 more

Open access · goldAbstract readLetter
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. [The role and research progress of NOTCH1 in T-cell acute lymphoblastic leukemia].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Jana HofDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
Corinne KoxDepartment of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
Stefanie Groeneveld-KrentzDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
Obul R BandapalliDepartment of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
Leonid KarawajewDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
Katharina SchedelDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
Joachim B KunzDepartment of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
Cornelia EckertDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
Wolf-Dieter LudwigHELIOS Medical Clinic Berlin-Buch, Clinic for Hematology, Oncology, Tumor Immunology and Palliative Care, Berlin.
Richard RateiHELIOS Medical Clinic Berlin-Buch, Clinic for Hematology, Oncology, Tumor Immunology and Palliative Care, Berlin.
Peter RheinDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
Günter HenzeDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
Martina U MuckenthalerDepartment of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
Andreas E KulozikDepartment of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
Arend von StackelbergDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
Renate Kirschner-SchwabeDepartment of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin r.kirschner@charite.de.
Heidelberg University · DECharité - Universitätsmedizin Berlin · DEUniversity Medical Center · USHelios Hospital Berlin-Buch · DEEuropean Molecular Biology Organization · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorMutationChildHumansImmunophenotypingKaplan-Meier EstimatePolymorphism, Single NucleotidePrecursor T-Cell Lymphoblastic Leukemia-LymphomaPrognosisProportional Hazards ModelsReceptor, Notch1RecurrenceTumor Suppressor Protein p53Biomarkers, TumorNOTCH1 protein, humanReceptor, Notch1TP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID28360149
PMCPMC5566048
OpenAlexW2603007887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.